Bortezomib, lenalidomide and dexamethasone (VRD) combination as salvage therapy in refractory angioimmunoblastic T cell lymphoma
2013 ◽
Vol 164
(5)
◽
pp. 750-752
◽
Keyword(s):
T Cell
◽